Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.47 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 2/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8567236 | 0.94 | FOLH1 (0.47) | DPP8DPP9DPP4FOLH1GSR | |
| SCHEMBL1888867 | 0.94 | FOLH1 (0.47) | DPP8DPP9DPP4FOLH1GSR | |
| SCHEMBL1649812 | 0.91 | FOLH1 (0.48) | DPP8DPP9DPP4FOLH1GSR | |
| SCHEMBL7751944 | 0.89 | DPP7 (0.50) | DPP8DPP9DPP4GSRDPP7 | |
| SCHEMBL7751947 | 0.89 | DPP7 (0.50) | DPP8DPP9DPP4GSRDPP7 | |
| SCHEMBL2183342 | 0.89 | FOLH1 (0.44) | DPP8DPP9DPP4FOLH1GSR | |
| SCHEMBL6255972 | 0.88 | DPP8 (0.47) | DPP8DPP9DPP4FOLH1GSR | |
| SCHEMBL6255984 | 0.88 | DPP8 (0.47) | DPP8DPP9DPP4FOLH1GSR | |
| SCHEMBL9142314 | 0.88 | DPP4 (0.54) | DPP8DPP9DPP4FOLH1GSR | |
| SCHEMBL2193972 | 0.85 | FOLH1 (0.43) | DPP8DPP9DPP4FOLH1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105683390-B | HbA1c measurement method using amadoriase acting on glycosylated peptide | 龟甲万株式会社 | 2021-02-26 | — | — | CN | claimed |
| US-4237047-A | FLUORESCENT SUBSTRATE FOR MEASURING ENZYME ACTIVITY | AJINOMOTO COMPANY, INCORPORATED (JP) | 1980-12-02 | — | — | US | claimed |
| CN-105683390-B | HbA1c measurement method using amadoriase acting on glycosylated peptide | 龟甲万株式会社 | 2021-02-26 | — | — | CN | disclosed |
| WO-2016044423-A1 | MICROBIAL BIOMASS COMPRISING FOOD PRODUCTS | SAVAGE RIVER, INC. dba BEYOND MEAT (US) | 2016-03-24 | — | — | WO | disclosed |
| US-20160073671-A1 | MICROBIAL BIOMASS COMPRISING FOOD PRODUCTS | BEYOND MEAT, INC.(F/K/A SAVAGE RIVER, INC.) | 2016-03-17 | — | — | US | disclosed |
| US-8198258-B2 | Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases | QUARK PHARMACEUTICALS INC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-20110201670-A1 | OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF FIBROTIC CONDITIONS AND OTHER DISEASES | QUARK PHARMACEUTICALS, INC. | 2011-08-18 | — | — | US | disclosed |
| EP-2330111-A2 | Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases | Quark Pharmaceuticals, Inc. (US) | 2011-06-08 | — | — | EP | disclosed |
| US-7939652-B2 | Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases | QUARK PHARMACEUTICALS INC. (US) | 2011-05-10 | — | — | US | disclosed |
| US-20100266574-A1 | Oligoribonucleotides and Methods of Use Thereof for Treatment of Fibrotic Conditions and Other Diseases | QUARK PHARMACEUTICALS, INC. | 2010-10-21 | — | — | US | disclosed |
| EP-1130961-B1 | STABILISATION OF MILK FROM TRANSGENIC ANIMALS | PHARMING INTELLECTUAL PTY BV (NL) | 2009-04-08 | — | — | EP | disclosed |
| US-20020019025-A1 | Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES (FR) | 2002-02-14 | — | — | US | disclosed |
| EP-1130961-A1 | STABILISATION OF MILK FROM TRANSGENIC ANIMALS | PPL Therapeutics (Scotland) Limited (GB) | 2001-09-12 | — | — | EP | disclosed |
| EP-1115745-A1 | PURIFICATION OF FIBRINOGEN FROM FLUIDS BY PRECIPITATION AND HYDROPHOIC INTERACTION CHROMATOGRAPHY | PPL Therapeutics (Scotland) Limited (GB) | 2001-07-18 | — | — | EP | disclosed |
| EP-1115742-A1 | PURIFICATION OF FIBRINOGEN FROM MILK BY USE OF CATION EXCHANGE CHROMATOGRAPHY | PPL Therapeutics (Scotland) Limited (GB) | 2001-07-18 | — | — | EP | disclosed |
| WO-2000030436-A1 | STABILISATION OF MILK FROM TRANSGENIC ANIMALS | PPL THERAPEUTICS (SCOTLAND) LTD. (GB) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000017234-A1 | PURIFICATION OF FIBRINOGEN FROM MILK BY USE OF CATION EXCHANGE CHROMATOGRAPHY | PPL THERAPEUTICS (SCOTLAND) LIMITED (GB) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000017239-A1 | PURIFICATION OF FIBRINOGEN FROM FLUIDS BY PRECIPITATION AND HYDROPHOBIC CHROMATOGRAPHY | PPL THERAPEUTICS (SCOTLAND) LIMITED (GB) | 2000-03-30 | — | — | WO | disclosed |
| US-4237047-A | FLUORESCENT SUBSTRATE FOR MEASURING ENZYME ACTIVITY | AJINOMOTO COMPANY, INCORPORATED (JP) | 1980-12-02 | — | — | US | disclosed |
| US-4237047-A | FLUORESCENT SUBSTRATE FOR MEASURING ENZYME ACTIVITY | AJINOMOTO COMPANY, INCORPORATED (JP) | 1980-12-02 | — | — | US | disclosed |